Novel DNA vaccine against Ebola virus safe, effective

Friday, 12 October 2018, 04:00 Hrs
43
cmt right
44
Comment Right
51
cmt right
16
cmt right
Printer Print Email Email


Scientists, including one of Indian-origin, have found that the novel synthetic DNA vaccine is safe against Ebola virus and offers a long-term alternative to traditional vaccines.

The team, from The Wistar Institute in Philadelphia, US, optimised a shorter, dose-sparing, immunisation regimen and simplified vaccine that can be directly administered into the skin. They targeted a virus surface protein called glycoprotein. 

This new approach induced rapid and protective immunity from virus challenges. 

Importantly, the approach showed strong immune responses one year after the last dose, supporting the long-term immunogenicity of the vaccine -- a particularly challenging area for Ebola vaccines.

"Synthetic non-viral based DNA technology allows for rapid vaccine development by delivery directly into the skin, resulting in consistent, potent and rapid immunity compared to traditional vaccine approaches," said lead researcher David B. Weiner, Director of Wistar's Vaccine and Immunotherapy Center. 

"An anti-Ebola virus DNA vaccine like this may provide an important new tool for protection, and we are excited to see what future studies will unveil," he added.

In the study, published in the Journal of Infectious Diseases, the team detected antibody levels were equal or higher to those reported for other vaccines currently being evaluated in the clinic.

"The success of intradermal delivery of a low-dose regimen is very encouraging," said Ami Patel, Ph.D., associate staff scientist in the Weiner Lab. "The ultimate goal of our work is to create effective and safe vaccines that are optimised for field use in at-risk areas."

Ebola virus disease is a serious and often fatal illness that can cause fever, headache, muscle pain, weakness, fatigue, diarrhoea, vomiting, stomach pain and haemorrhage (severe bleeding).

First discovered in humans in 1976 in the Democratic Republic of the Congo, the largest outbreak occurred in West Africa from 2014 to 2016, which claimed more than 11,000 lives, according to the World Health Organization.

The death rate is about 50 per cent and the virus is spread by contact with contaminated body fluids, including blood and semen.

While there are no licensed treatments available for Ebola virus disease yet, multiple experimental therapies are being developed.



Read more news:

Google reveals Pixel 3, bigger Pixel 3 XL smartphone



Source: IANS
SPOTLIGHT
Finance
The Department of Telecommunications (DoT) in consultation with the Finance Ministry plans to spli..
Technology
Facebook ruled out a cyber attack on its products Whatsapp, Instagram and Messenger, which suffere..
US Indian
An Indian-American teenager has been conferred with the 2019 National STEM (Science, Technolog..
Gadgets
Chipset-making giant Qualcomm has listed chipsets such as Snapdragon 855, 845, 710, 675 and 67..
Business
Hinduja Global Solutions here on Monday said it has set up a centre of excellence to train disable..
Career
IIT Roorkee organized an MoU exchanging ceremony between the Govt. of India Department of Scie..
Enterprise IT
PayByPhone, the global leader in mobile parking payments, today announced that it will appoint And..
Entertainment
First things first. "Made In Heaven" is the sexiest webseries India has produced, no doubt about i..
Startup City
India Accelerator, a GAN partnered, mentorship-driven, acceleration program hosted ‘The Inner Ci..